Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sales Reps, Overtime & The Labor Dept
Pharmalot
Tuesday, April 17, 2012 - 10:45am
tags:
overtime lawsuits, Department of Labor, drug reps
Second Physician Survey Supports Prescription Data: Expecting 1Q Fusilev Growth
Seeking Alpha
Tuesday, April 17, 2012 - 10:42am
tags:
Fusilev, physicians, Spectrum Pharmaceuticals, Allos, Teva Pharmaceuticals
NeurogesX seeks partners for pain drugs
Reuters
Tuesday, April 17, 2012 - 10:40am
tags:
NeurogesX, Qutenza, neuropathic pain
Forest Laboratories Inc. Earnings: Four Quarters in a Row of Falling Profit
Wall St. Cheat Sheet
Tuesday, April 17, 2012 - 10:39am
tags:
Forest Labs, earnings
Illumina Win in Board Contest May Signal Long Roche Fight
Bloomberg
Tuesday, April 17, 2012 - 10:29am
tags:
Roche, M&A, Illumina
Sequenom rises on new Down Syndrome test forecast
Yahoo/AP
Tuesday, April 17, 2012 - 10:26am
tags:
Downs Syndrome, Sequenom, MaterniT21
Pharmacy benefits manager Express Scripts sees slower growth in prescription drug spending
Yahoo/AP
Tuesday, April 17, 2012 - 10:22am
tags:
drug sales, Express Scripts
Merck's New Vaccine, Partnerships Will Drive Stock Higher
Seeking Alpha
Tuesday, April 17, 2012 - 10:22am
tags:
Merck, vaccines, AstraZeneca, Eli Lilly, GSK, Pfizer, Sun Pharma, shingles, Zostavax
2012 Is Looking Like A Turning Point For J&J
Seeking Alpha
Tuesday, April 17, 2012 - 10:20am
tags:
JNJ, Abbott Laboratories, Covidien, Stryker
Merck Could Plummet On FDA's Warning For Propecia
Seeking Alpha
Tuesday, April 17, 2012 - 10:18am
tags:
Merck, FDA, Propecia, Proscar, GSK, Eli Lilly, Pfizer
Johnson & Johnson Reports Mixed First Quarter Earnings
Yahoo/Business Insider
Tuesday, April 17, 2012 - 8:00am
tags:
JNJ, earnings
Lilly Declares Second-Quarter 2012 Dividend
Yahoo
Monday, April 16, 2012 - 4:04pm
tags:
Eli Lilly, dividends
Questcor Will Skyrocket Into 2013
Seeking Alpha
Monday, April 16, 2012 - 4:03pm
tags:
Questcor, Acthar, Sanofi, Novartis
J&J Must Pay $40 Million to Boston Scientific, Judge Says
Bloomberg
Monday, April 16, 2012 - 4:01pm
tags:
JNJ, Boston Scientific, settlements, patents, coronary stent system
Science Vs. Hedge Funds: Influences On New Drug Approval Process
Seeking Alpha
Monday, April 16, 2012 - 1:49pm
tags:
hedge funds, Arena Pharmaceuticals, Avanir, Chelsea Therapeutics, Dendreon, Neoprobe, Vivus
With Zostavax supplies restored, Merck aims for revival
Fierce Pharma
Monday, April 16, 2012 - 1:46pm
tags:
Merck, Zostavax, shingles
Idenix Will Sink Without Drug Success, Partnership
Motley Fool
Monday, April 16, 2012 - 1:44pm
tags:
Idenix, IDX184, hepatitis C
Supreme Court To Hear Overtime Rep Case Today
Pharmalot
Monday, April 16, 2012 - 1:43pm
tags:
overtime lawsuits, Supreme Court
Amgen’s Sharer: Mostly, ‘I Was An Awful Listener’
Pharmalot
Monday, April 16, 2012 - 1:41pm
tags:
Amgen, Kevin Sharer, Pharma CEOs
FDA Schedules Meeting With Cellceutix on New Psoriasis Drug
Yahoo/Marketwire
Monday, April 16, 2012 - 11:58am
tags:
FDA, Cellceutix, psoriasis, Prurisol

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.